Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Shareholder vote
confidence 98%
filed 2026-05-29
Item 5.07
This Item 5.07 disclosure reports the results of FTAI Aviation's 2026 Annual General Meeting held on May 28, 2026, including: (1) election of three Class I directors with vote tallies for each nominee; (2) non-binding advisory vote on named executive officer compensation; and (3) ratification of KPMG LLP as independent auditor. The filing presents voting results in tabular form for each proposal, which is the core content of shareholder vote result disclosures.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-05-29
Item 5.07
This Item 5.07 disclosure reports the results of an annual stockholder meeting held on May 27, 2026, including voting outcomes for director elections (Proposal #1) and advisory compensation approval (Proposal #2). The filing presents vote tallies (FOR, AGAINST, WITHHELD, ABSTAIN, BROKER NON-VOTES) for each proposal, which is the standard format for shareholder vote results required under Item 5.07 of Form 8-K.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-29
Item 5.07
Nu Skin held its Annual Meeting of Stockholders on May 28, 2026, at which stockholders voted on four proposals: election of nine directors, advisory approval of executive compensation, approval of an Amended and Restated 2024 Omnibus Incentive Plan, and ratification of PricewaterhouseCoopers LLP as auditor. All four proposals passed with substantial majorities.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 45%
filed 2026-05-29
Item 5.07
The filing discloses shareholder vote results from an annual or special meeting, with incorporation of Item 5.02 content regarding the election of 11 directors to KKR's Board, including Henry R. Kravis and George R. Roberts. The substantive voting outcome is that all directors were re-elected, though the Item 5.07 section itself contains limited detail beyond signature blocks.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-29
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of the 2026 Annual Meeting of Shareholders held on May 29, 2026. The filing presents voting results for two matters: (1) election of Class I director James L. Hamilton with specific vote counts (38.5M for, 32M withheld, 31.8M broker non-votes), and (2) ratification of KPMG LLP as independent auditor (101.7M for, 405K against, 177K abstentions). Shareholder vote results are material to investors as they reflect governance outcomes and auditor selection.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-29
Item 5.07
Edesa Biotech held an Annual Meeting of shareholders on which four proposals were voted: election of seven directors, advisory vote on executive compensation, approval of an amendment to the 2019 Equity Incentive Compensation Plan increasing available shares by 750,000 and eliminating annual per-participant option grant limits, and appointment of MNP LLP as auditors. All proposals passed with substantial majorities.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-29
Item 5.07
This is a clear disclosure of shareholder vote results from Rani Therapeutics' annual meeting held on May 28, 2026. The filing reports voting outcomes for two proposals: (1) election of seven director nominees, with vote tallies for each candidate (For/Withheld/Broker Non-Votes), and (2) ratification of CBIZ CPAs P.C. as independent auditor. This is the quintessential Item 5.07 disclosure and is material to investors as it documents the composition of the board and auditor selection.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-29
Item 5.07
This is a clear Item 5.07 disclosure of shareholder meeting results held on May 28, 2026. The filing presents voting tallies for four proposals: election of nine board directors, advisory approval of named executive officer compensation, ratification of KPMG LLP as independent auditor, and amendment of the 2019 Omnibus Incentive Compensation Plan. All proposals passed with substantial majorities, making this a routine but material shareholder governance disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-29
Item 5.07
This is a clear disclosure of shareholder vote results from ProKidney Corp.'s 2026 Annual Meeting of Stockholders held on May 28, 2026. The filing reports voting outcomes for director elections (William F. Doyle, Alan M. Lotvin, and Brian J.G. Pereira) and ratification of Ernst & Young LLP as independent auditor, which are routine but material governance matters that affect investor understanding of board composition and audit oversight.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-29
Item 5.07
ACADIA held its Annual Meeting on May 29, 2026, with shareholders voting on and approving multiple matters including the election of three Class I directors (James M. Daly, Edmund P. Harrigan, and Adora Ndu), advisory approval of named executive officer compensation, ratification of Ernst & Young LLP as auditor, and approval of an amendment to the 2024 Equity Incentive Plan increasing authorized shares by 5,209,670.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-29
Item 5.07
This Item 5.07 disclosure reports the complete tabulation of stockholder votes from Neumora's Annual Meeting of Stockholders held on May 27, 2026, covering four proposals: election of three Class III directors, ratification of Ernst & Young LLP as independent auditor, advisory vote on named executive officer compensation, and advisory vote on frequency of future compensation votes. The filing presents vote counts (For, Against, Withheld, Abstentions, and Broker Non-Votes) for each proposal, which is the standard format for shareholder vote results disclosures required under Item 5.07.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-29
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of FiscalNote's annual meeting of stockholders held on May 27, 2026. The filing presents voting results for four proposals: election of two Class I directors (Compton and Hwang), advisory approval of named executive officer compensation, frequency of future advisory compensation votes, and ratification of RSM US LLP as independent auditor. The tabular presentation of vote counts (For, Against, Abstain, Broker Non-Votes) is the standard format for shareholder vote result disclosures.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-29
Item 5.07
This is a classic Item 5.07 disclosure of shareholder vote results from Equillium's 2026 Annual Meeting held on May 28, 2026. The filing reports voting outcomes on four proposals: election of directors (with Peter Colabuono not renominated and board size reduced from seven to six), approval of a reverse stock split authorization (1-for-2 to 1-for-20 ratio at board discretion), ratification of Crowe LLP as independent auditor, and approval to increase authorized common shares from 200 million to 400 million. These results are material to investors as they reflect shareholder decisions on governance, capital structure, and audit oversight.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-29
Item 5.07
This is a classic Item 5.07 disclosure of shareholder vote results from Impinj's Annual Meeting held May 28, 2026. The filing reports voting outcomes on four proposals: election of seven directors, ratification of Ernst & Young LLP as auditor, advisory approval of named executive officer compensation, and approval of the 2026 Equity Incentive Plan. All proposals passed with substantial majorities, making this a material disclosure of governance outcomes that investors rely upon to assess board composition and compensation arrangements.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-29
Item 5.07
This is a clear disclosure of shareholder voting results from Aveanna Healthcare's 2026 Annual Meeting of Stockholders held on May 29, 2026. The filing presents final voting tallies for three proposals: election of three Class II directors (Rodney D. Windley, Sam Weil, and Steven E. Rodgers), ratification of Ernst & Young LLP as independent auditor, and advisory approval of named executive officer compensation. This is a routine but material Item 5.07 disclosure required by SEC rules.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-29
Item 5.07
Stockholders voted at the Annual Meeting on four proposals: election of three Class II directors (Diane Biagianti, Diane Brink, and Karl-Thomas Neumann), advisory approval of named executive officer compensation, approval of an amendment to the 2021 Omnibus Equity Incentive Plan increasing shares reserved by 17,000,000, and ratification of KPMG LLP as independent auditor. All proposals passed with substantial majorities.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-29
Item 5.07
Entravision held its 2026 Annual Meeting of Stockholders with voting results on seven director elections, ratification of Deloitte & Touche as independent auditor, advisory approval of named executive officer compensation, and approval of an amendment to the 2004 Equity Incentive Plan increasing authorized shares by 6,000,000.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-29
Item 5.07
This is a classic Item 5.07 disclosure of shareholder vote results from Alta Equipment Group's Annual Meeting of Stockholders held on May 29, 2026. The filing reports voting outcomes on four proposals: election of three Class II directors (Ryan Greenawalt, Andrew Studdert, Colin Wilson), ratification of Deloitte & Touche LLP as independent auditor, advisory approval of named executive officer compensation, and approval of the first amendment to the 2020 Omnibus Incentive Plan. All proposals passed with substantial majorities, making this a material disclosure of governance and compensation decisions approved by shareholders.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-29
Item 5.07
This is a clear disclosure of shareholder voting results from Novanta Inc.'s annual meeting held on May 28, 2026. The filing reports the outcomes of three proposals: election of nine directors, advisory approval of executive compensation, and appointment of Deloitte & Touche LLP as independent auditor. All three proposals passed with substantial majorities. This is a quintessential Item 5.07 disclosure and is material to investors as it confirms the composition of the board and auditor for the upcoming fiscal year.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-29
Item 5.07
This is a clear Item 5.07 disclosure of shareholder vote results from Neuronetics' Annual Meeting of Stockholders held on May 28, 2026. The filing reports final voting tallies for four proposals: election of seven directors, ratification of KPMG LLP as independent auditor, advisory approval of executive compensation, and approval of the 2026 Equity Incentive Plan. All proposals passed with majority support, and the disclosure is material as it reflects stockholder governance decisions affecting board composition, audit oversight, and equity incentive arrangements.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-29
Item 5.07
This is a clear Item 5.07 disclosure of shareholder vote results from a special meeting held on May 28, 2026. The filing reports the voting outcomes on the Merger Proposal to adopt and approve the Merger Agreement between FONAR Corporation and Parent/Merger Sub entities, with detailed vote tallies showing approval by the requisite majorities (Company Stockholder Approval: 13,124,769 for vs. 551,079 against; Disinterested Stockholder Approval and Section 203 Approval also obtained). The merger is material to investors as it represents a change of control transaction expected to close on June 3, 2026.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-29
Item 5.07
Tenaya Therapeutics held its Annual Meeting of Stockholders on May 27, 2026, with shareholders voting on three proposals: election of three Class II directors (Amy Burroughs, Karah Parschauer, and Catherine Stehman-Breen), ratification of Deloitte & Touche LLP as independent auditor, and approval of the amended 2021 Equity Incentive Plan. All three proposals passed with substantial majorities.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-05-29
Item 5.07
The filing explicitly discloses Item 5.07 regarding "voting results and the conclusion of the Annual Meeting" with a press release issued on May 25, 2026. This is a direct disclosure of shareholder vote results from an annual meeting, which is the core definition of the shareholder_vote_results event type. Annual meeting voting outcomes are material to investors as they determine board composition and approval of key corporate matters.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-05-29
Item 5.07
This is a Form 8-K Item 5.07 disclosure of shareholder vote results from the reconvened 2025 Annual Meeting of Stockholders held on May 29, 2026. The filing reports voting outcomes for three proposals: election of a Class I director (Arphing Lee), ratification of Bush & Associates CPA LLC as independent auditor, and approval of the 2025 Stock Incentive Plan. All three proposals passed, making this a material disclosure of shareholder actions that affects the composition of the board and approval of equity compensation arrangements.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-29
Item 5.07
This Item 5.07 disclosure presents the complete results of The Mosaic Company's 2026 Annual Meeting of Stockholders, including voting tallies for director elections (all twelve directors elected), ratification of KPMG LLP as independent auditor, and advisory approval of executive compensation. The detailed vote counts for each matter are the core content of a shareholder_vote_results event.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-29
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of Roblox's 2026 Annual Meeting of Stockholders held on May 28, 2026. The filing presents voting outcomes for three proposals: election of three directors (David Baszucki, Gregory Baszucki, and Dennis Durkin), advisory approval of named executive officer compensation, and ratification of Deloitte & Touche LLP as independent auditor. The detailed vote tallies (votes for, against, abstentions, and broker non-votes) are the core content of this Item 5.07 disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-29
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of Employers Holdings' 2026 annual meeting of stockholders held on May 28, 2026. The filing presents voting results for three matters: election of eight directors, advisory approval of named executive officer compensation, and ratification of Ernst & Young LLP as independent auditor. The detailed vote tallies (for, against, abstentions, broker non-votes) for each director and proposal are the core content of the filing, making this unambiguously a shareholder_vote_results event.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-29
Item 5.07
This Item 5.07 filing discloses the final results of American Coastal Insurance's 2026 Annual Meeting of stockholders, including voting outcomes for two proposals: election of five Class B directors and ratification of Deloitte & Touche, LLP as independent auditor. The detailed vote tallies (For, Against, Abstained, Broker Non Votes) for each director and the auditor ratification are the core disclosure, making this a textbook shareholder_vote_results event that is material to investors assessing board composition and audit oversight.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-29
Item 5.07
This is a clear disclosure of shareholder vote results from Broadwind's Annual Meeting of Stockholders held on May 28, 2026. The filing reports voting outcomes on three matters: (i) election of five directors, (ii) non-binding advisory vote on named executive officer compensation ("Say-on-Pay"), and (iii) ratification of RSM US LLP as independent auditor. All three votes passed with substantial majorities. This is a routine but material disclosure required under Item 5.07 of Form 8-K.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-29
Item 5.07
This is a clear disclosure of shareholder vote results from HealthStream's May 28, 2026 annual meeting, covering three proposals: election of three Class II directors, ratification of Ernst & Young LLP as independent auditor, and approval of a non-binding say-on-pay resolution. The filing presents final vote tallies for each proposal, which is the quintessential content of Item 5.07 disclosures and materially informs investors about shareholder governance actions.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-29
Item 5.07
This is a classic Item 5.07 disclosure reporting the final results of Coastal Financial's 2026 annual meeting of shareholders held on May 27, 2026. The filing presents voting results for three matters: election of directors (Delorier, Hovde, Patterson, Tisdel, and Chapman), ratification of Baker Tilly US, LLP as independent auditor, and an advisory vote on executive compensation. The detailed vote tallies (For/Against/Abstain/Broker Non-Votes) for each proposal are the core content of this disclosure, which is material to investors assessing corporate governance and board composition.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-29
Item 5.07
This Item 5.07 disclosure reports the results of SiTime Corporation's Annual Meeting of Stockholders held on May 29, 2026, with voting tallies for three proposals: election of three Class I directors (Torsten G. Kreindl, Ganesh Moorthy, and Akira Takata), advisory approval of named executive officer compensation, and ratification of Deloitte & Touche LLP as independent auditor. The detailed vote counts (For, Against/Withheld, Abstain, and Broker Non-Votes) for each proposal are the core disclosure, which is the defining characteristic of shareholder vote results under Item 5.07.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-29
Item 5.07
This is a classic Item 5.07 disclosure of shareholder vote results from AtlasClear's May 27, 2026 annual meeting. The filing presents final voting tallies for three proposals: election of six directors, approval of a 15,000,000-share increase to the 2024 Equity Incentive Plan, and ratification of Haynie & Company as independent auditor. All three proposals passed with majority support, and the detailed vote counts (For/Against/Withheld/Abstentions/Broker Non-Votes) are the core substance of the disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 85%
filed 2026-05-29
The filing's primary substantive disclosure is Item 5.07, which reports the results of the 2026 Annual Meeting of Stockholders held on May 28, 2026. The filing details voting outcomes on six director elections, a say-on-pay proposal, a reverse stock split proposal, an authorized stock increase proposal, and auditor ratification. While Item 5.02 addresses new RSU and RSA award agreement forms (an executive compensation matter), the bulk of the 8-K content and materiality centers on the shareholder vote results, particularly the failed Authorized Stock Increase Proposal (427,158 for vs. 555,147 against), which would be material to investors assessing the company's capital structure flexibility.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-05-29
The filing discloses results of AVAX One Technology's Annual Meeting of Shareholders held on May 29, 2026, under Item 5.07. The company reported voting outcomes on four matters: election of five directors (all approved), ratification of CBIZ CPAs P.C. as independent auditor (approved), approval of a 1:2 to 1:12 reverse stock split (approved), and advisory approval of 2025 named executive officer compensation (approved). These shareholder vote results are material to investors as they reflect governance decisions and corporate actions.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-29
The 8-K discloses Item 5.07 results from the May 22, 2026 Annual Meeting of stockholders, reporting voting outcomes on two proposals: (1) election of nine directors with detailed vote tallies (For/Withheld/Broker Non-Votes), and (2) ratification of Crowe LLP as independent auditor. This is a textbook shareholder vote results disclosure, material to investors as it confirms board composition and auditor appointment.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-29
Item 5.07
This 8-K Item 5.07 discloses the results of Bandwidth Inc.'s 2026 Annual Meeting of Stockholders held on May 28, 2026, including voting outcomes on four proposals: election of Class III directors (David A. Morken and Rebecca G. Bottorff), ratification of Ernst & Young LLP as independent auditor, advisory approval of named executive officer compensation, and advisory vote on compensation vote frequency. The filing presents detailed vote tallies (For/Against/Withheld/Broker Non-Votes) for each proposal, which is the core disclosure required under Item 5.07.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-29
Item 5.07
This is a clear Item 5.07 disclosure of shareholder vote results from Freshworks Inc.'s 2026 Annual Meeting held on May 28, 2026. The filing reports voting outcomes for four proposals: election of Class II directors (Roxanne S. Austin, Sameer Gandhi, Frank Pelzer, Dennis Woodside), advisory approval of executive compensation, frequency of say-on-pay votes, and ratification of Deloitte & Touche LLP as independent auditor. All proposals passed with substantial majorities, making this a material governance event that affects investor understanding of board composition and compensation oversight.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-29
Item 5.07
This is a clear disclosure of shareholder voting results from Life360's Annual Meeting of Stockholders held on May 28, 2026. The filing reports the certified results of three proposals: election of four Class I directors (Proposal 1), advisory vote on executive compensation (Proposal 2), and ratification of Deloitte & Touche LLP as independent auditor (Proposal 3), with detailed vote tallies for each. This is a quintessential Item 5.07 disclosure and is material as it reflects stockholder approval of key governance matters.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-29
Item 5.07
This is a clear disclosure of shareholder vote results from Community West Bancshares' Annual Meeting of Shareholders held on May 27, 2026. The filing presents tabulated voting results for three matters: election of 13 directors, ratification of Baker Tilly LLP as independent auditor, and a non-binding advisory vote on executive compensation. These are routine but material governance matters that affect investor understanding of board composition and corporate oversight.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-29
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of Maplebear Inc.'s 2026 Annual Meeting of Stockholders held on May 22, 2026. The filing presents voting results for three proposals: election of two Class III directors (Meredith Kopit Levien and Lily Sarafan both elected), ratification of PricewaterhouseCoopers LLP as independent auditor, and non-binding advisory approval of named executive officer compensation. All three proposals passed with substantial majorities, making this a routine but material shareholder vote results disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-29
Item 5.07
Silgan Holdings held its annual meeting of stockholders on May 26, 2026, with voting results on four matters: election of three directors, approval of the First Amendment to the 2004 Stock Incentive Plan, ratification of Ernst & Young LLP as independent auditor, and a non-binding advisory vote on named executive officer compensation.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-29
Item 5.07
Ellington Financial held its 2026 Annual Meeting of Stockholders on May 28, 2026, with shareholders voting on four proposals: election of directors, advisory say-on-pay vote, ratification of PricewaterhouseCoopers LLP as auditors, and approval of the 2026 Equity Incentive Plan. The filing discloses detailed voting results (For, Against, Abstentions, and Broker Non-Votes) for each proposal.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-29
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of Castle Biosciences' 2026 annual meeting of stockholders held on May 28, 2026. The filing presents voting results for four proposals: election of three Class I directors (Ellen Goldberg, Miles D. Harrison, Tiffany P. Olson), ratification of KPMG LLP as independent auditor, advisory approval of named executive officer compensation, and approval of the non-employee director compensation policy. Shareholder vote results are material to investors as they reflect governance outcomes and stakeholder approval of key corporate matters.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-29
Item 5.07
This is a clear disclosure of shareholder voting results from Meta's May 27, 2026 annual meeting of shareholders. The filing reports detailed vote tallies for all twelve proposals, including director elections (all twelve nominees elected), ratification of Ernst & Young LLP as auditor (approved), and twelve shareholder proposals (all rejected). This is a quintessential Item 5.07 disclosure and is material to investors as it documents the outcome of significant corporate governance matters and shareholder engagement.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-29
Item 5.07
Skye Bioscience held its 2026 Annual Meeting of Stockholders on May 26, 2026, with shareholders voting on four proposals: election of six directors, ratification of CBIZ CPAs P.C. as auditor, approval of a Charter Amendment to increase authorized common shares from 100 million to 300 million, and advisory approval of named executive officer compensation. All proposals received final vote tallies disclosed in the filing.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-29
Item 5.07
This Item 5.07 filing discloses the final voting results from Octave Specialty Group's Annual Meeting of Stockholders held on May 28, 2026, including election of seven directors, advisory vote on named executive officer compensation, ratification of Ernst & Young LLP as auditor, and approval of the 2026 Incentive Compensation Plan. The detailed vote tallies for each action are the core disclosure, making this a textbook shareholder_vote_results event that is material to investors assessing corporate governance and executive compensation matters.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-29
Item 5.07
Shareholders voted at the May 27, 2026 Annual Meeting on four proposals: election of three Class I directors (McKenna, Turtle, Stelzer), advisory vote on named executive officer compensation, ratification of KPMG LLP as independent auditor, and approval of the amended ESPP. Final vote tallies were disclosed for each proposal.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-29
Item 5.07
This is a clear disclosure of shareholder voting results from Hertz Global Holdings' 2026 Annual Meeting of Stockholders held on May 28, 2026. The filing reports final voting tallies for three matters: election of two directors (Lucy Clark Dougherty and Evangeline Vougessis), ratification of Ernst & Young LLP as independent auditor, and advisory approval of named executive officers' compensation. This is a textbook Item 5.07 shareholder vote results disclosure, and the outcomes (both directors elected, auditor ratified, compensation approved) are material to investors' understanding of corporate governance and board composition.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-29
Item 5.07
DigitalBridge held its Annual Meeting of Stockholders on May 28, 2026, with stockholders voting on four proposals: election of nine directors, advisory vote on executive compensation, approval of an omnibus stock incentive plan amendment increasing authorized shares by 6,000,000, and ratification of Ernst & Young LLP as independent auditor.
View raw filing on EDGAR →